Priority Research Papers
|
| Multimodal targeting of tumor vasculature and cancer stemlike cells in sarcomas with VEGFA inhibition HIF1α inhibition and hypoxiaactivated chemotherapy |
|
https://doi.org/10.18632/oncotarget.10212
|
| 42844-42858 |
|
| Integrated in vivo genetic and pharmacologic screening identifies coinhibition of EGRF and ROCK as a potential treatment regimen for triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.10230
|
| 42859-42872 |
Research Papers: Gerotarget (Focus on Aging)
|
| Do human Blymphocytes avoid aging until 60 years |
|
https://doi.org/10.18632/oncotarget.10146
|
| 42873-42880 |
|
| Baicalein is an available antiatherosclerotic compound through modulation of nitric oxiderelated mechanism under oxLDL exposure |
|
https://doi.org/10.18632/oncotarget.10263
|
| 42881-42891 |
Research Papers: Pathology
|
| Protein inhibitor of activated STAT 4 PIAS4 regulates proinflammatory transcription in hepatocytes by repressing SIRT1 |
|
https://doi.org/10.18632/oncotarget.9864
|
| 42892-42903 |
|
| Tracing the origin of Treponema pallidum in China using nextgeneration sequencing |
|
https://doi.org/10.18632/oncotarget.10154
|
| 42904-42918 |
Research Papers: Immunology
|
| Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Tolllike receptor agonists |
|
https://doi.org/10.18632/oncotarget.10190
|
| 42919-42942 |
|
| Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI |
|
https://doi.org/10.18632/oncotarget.10260
|
| 42943-42952 |
|
| IL17 downregulates the immunosuppressive capacity of olfactory ectomesenchymal stem cells in murine collageninduced arthritis |
|
https://doi.org/10.18632/oncotarget.10261
|
| 42953-42962 |
|
| In vitro studies implicate an imbalanced activation of dendritic cells in the pathogenesis of murine autoimmune pancreatitis |
|
https://doi.org/10.18632/oncotarget.10265
|
| 42963-42977 |
Research Papers
|
| Highdensity lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.7160
|
| 42978-42987 |
|
| Liquid biopsy monitoring uncovers acquired RASmediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.8943
|
| 42988-42995 |
|
| A key role of GARP in the immune suppressive tumor microenvironment |
|
https://doi.org/10.18632/oncotarget.9598
|
| 42996-43009 |
|
| Tailored chemokine receptor modification improves homing of adoptive therapy T cells in a spontaneous tumor model |
|
https://doi.org/10.18632/oncotarget.9280
|
| 43010-43026 |
|
| RIC versus MAC UCBT in adults with AML: A report from Eurocord the ALWP and the CTIWP of the EBMT |
|
https://doi.org/10.18632/oncotarget.9599
|
| 43027-43038 |
|
| Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance |
|
https://doi.org/10.18632/oncotarget.9915
|
| 43039-43051 |
|
| The genetic landscape of dural marginal zone lymphomas |
|
https://doi.org/10.18632/oncotarget.9678
|
| 43052-43061 |
|
| BO1055 a novel DNA crosslinking agent with remarkable low myelotoxicity shows potent activity in sarcoma models |
|
https://doi.org/10.18632/oncotarget.9657
|
| 43062-43075 |
|
| Epithelial ovarian cancersecreted exosomal miR2223p induces polarization of tumorassociated macrophages |
|
https://doi.org/10.18632/oncotarget.9246
|
| 43076-43087 |
|
| Importance of the residue 190 on bactericidal activity of the bactericidal/permeabilityincreasing protein 5 |
|
https://doi.org/10.18632/oncotarget.9292
|
| 43088-43094 |
|
| Targeting glioma stem cells enhances antitumor effect of boron neutron capture therapy |
|
https://doi.org/10.18632/oncotarget.9355
|
| 43095-43108 |
|
| Angiogenin contributes to bladder cancer tumorigenesis by DNMT3bmediated MMP2 activation |
|
https://doi.org/10.18632/oncotarget.10097
|
| 43109-43123 |
|
| Wntbetacatenin pathway signals metastasisassociated tumor cell phenotypes in triple negative breast cancers |
|
https://doi.org/10.18632/oncotarget.8988
|
| 43124-43149 |
|
| Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells |
|
https://doi.org/10.18632/oncotarget.9504
|
| 43150-43161 |
|
| Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells |
|
https://doi.org/10.18632/oncotarget.9012
|
| 43162-43176 |
|
| Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck |
|
https://doi.org/10.18632/oncotarget.9506
|
| 43177-43187 |
|
| The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer |
|
https://doi.org/10.18632/oncotarget.9668
|
| 43188-43198 |
|
| A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis abrogate clonogenic survival and improve tumor control in models of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.9774
|
| 43199-43219 |
|
| Phosphorylation of Notch1 by Pim kinases promotes oncogenic signaling in breast and prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.9215
|
| 43220-43238 |
|
| Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.9755
|
| 43239-43255 |
|
| Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3mediated repression of PHLPP1 expression |
|
https://doi.org/10.18632/oncotarget.9673
|
| 43256-43266 |
|
| Human HLAA*02:01/CHM1+ allorestricted T cell receptor transgenic CD8+ T Cells specifically inhibit Ewing sarcoma growth in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.9218
|
| 43267-43280 |
|
| Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.9674
|
| 43281-43294 |
|
| The role of Wnt/βcatenin signaling pathway in melanoma epithelialtomesenchymallike switching: evidences from patientsderived cell lines |
|
https://doi.org/10.18632/oncotarget.9232
|
| 43295-43314 |
|
| The impact of intermittent versus continuous exposure to EGFR tyrosine kinase inhibitor on selection of EGFR T790Mmutant drugresistant clones in a lung cancer cell line carrying activating EGFR mutation |
|
https://doi.org/10.18632/oncotarget.9703
|
| 43315-43323 |
|
| 1415EET induces the infiltration and tumorpromoting function of neutrophils to trigger the growth of minimal dormant metastases |
|
https://doi.org/10.18632/oncotarget.9709
|
| 43324-43336 |
|
| NEAT1 upregulates EGCGinduced CTR1 to enhance cisplatin sensitivity in lung cancer cells |
|
https://doi.org/10.18632/oncotarget.9712
|
| 43337-43351 |
|
| Antitax interacting protein1 TIP1 monoclonal antibody targets human cancers |
|
https://doi.org/10.18632/oncotarget.9713
|
| 43352-43362 |
|
| Ecadherin reexpression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells |
|
https://doi.org/10.18632/oncotarget.9715
|
| 43363-43375 |
|
| PIK3C2A mRNA functions as a miR124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.9716
|
| 43376-43389 |
|
| Sirt3mediated mitophagy protects tumor cells against apoptosis under hypoxia |
|
https://doi.org/10.18632/oncotarget.9717
|
| 43390-43400 |
|
| Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating βcatenin signaling pathway |
|
https://doi.org/10.18632/oncotarget.9726
|
| 43401-43411 |
|
| Cellfree DNA mutations as biomarkers in breast cancer patients receiving tamoxifen |
|
https://doi.org/10.18632/oncotarget.9727
|
| 43412-43418 |
|
| Loss of miR1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B |
|
https://doi.org/10.18632/oncotarget.9728
|
| 43419-43431 |
|
| Urine gammasynuclein as a biomarker for the diagnosis of bladder cancer |
|
https://doi.org/10.18632/oncotarget.9468
|
| 43432-43441 |
|
| Chemotherapyrelated cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs |
|
https://doi.org/10.18632/oncotarget.9779
|
| 43442-43460 |
|
| Mediation of the malignant biological characteristics of gastric cancer cells by the methylated CpG islands in RNF180 DNA promoter |
|
https://doi.org/10.18632/oncotarget.9494
|
| 43461-43474 |
|
| Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.9782
|
| 43475-43491 |
|
| MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis |
|
https://doi.org/10.18632/oncotarget.9523
|
| 43492-43503 |
|
| BET bromodomain inhibitors suppress EWSFLI1dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma |
|
https://doi.org/10.18632/oncotarget.9762
|
| 43504-43517 |
|
| HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy |
|
https://doi.org/10.18632/oncotarget.9846
|
| 43518-43533 |
|
| The transcription factor FOXN3 inhibits cell proliferation by downregulating E2F5 expression in hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.9780
|
| 43534-43545 |
|
| Evaluation and characterization of antiRalA autoantibody as a potential serum biomarker in human prostate cancer |
|
https://doi.org/10.18632/oncotarget.9869
|
| 43546-43556 |
|
| Targeted nextgeneration sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index an implication for pathogenesis |
|
https://doi.org/10.18632/oncotarget.9618
|
| 43557-43569 |
|
| Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones |
|
https://doi.org/10.18632/oncotarget.9781
|
| 43570-43587 |
|
| Long noncoding RNA CPS1IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF1α activity and inhibiting epithelialmesenchymal transition |
|
https://doi.org/10.18632/oncotarget.9635
|
| 43588-43603 |
|
| Profiling the dynamic expression of checkpoint molecules on cytokineinduced killer cells from nonsmallcell lung cancer patients |
|
https://doi.org/10.18632/oncotarget.9871
|
| 43604-43615 |
|
| Multitargeting NGRmodified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving antiglioma therapy |
|
https://doi.org/10.18632/oncotarget.9889
|
| 43616-43628 |
|
| Immunogenicity of mammary tumor cells can be induced by shikonin via direct bindinginterference with hnRNPA1 |
|
https://doi.org/10.18632/oncotarget.9660
|
| 43629-43653 |
|
| Overexpression of transient receptor potential mucolipin2 ion channels in gliomas: role in tumor growth and progression |
|
https://doi.org/10.18632/oncotarget.9661
|
| 43654-43668 |
|
| The association between BMI and gallbladder cancer risk: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.9664
|
| 43669-43679 |
|
| The prognostic value of lymph nodes count on survival of patients with nodenegative gastric cancer |
|
https://doi.org/10.18632/oncotarget.9845
|
| 43680-43688 |
|
| Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.9905
|
| 43689-43702 |
|
| Polymorphisms in TIM3 and breast cancer susceptibility in Chinese women: A casecontrol study |
|
https://doi.org/10.18632/oncotarget.9665
|
| 43703-43712 |
|
| Targeting ACLY sensitizes castrationresistant prostate cancer cells to AR antagonism by impinging on an ACLYAMPKAR feedback mechanism |
|
https://doi.org/10.18632/oncotarget.9666
|
| 43713-43730 |
|
| Redoxsensitive MAPK and Notch3 regulate fibroblast differentiation and activation: a dual role of ERK1/2 |
|
https://doi.org/10.18632/oncotarget.9667
|
| 43731-43745 |
|
| Dual targeting of PI3K and MEK enhances the radiation response of KRAS mutated nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.9670
|
| 43746-43761 |
|
| Combination of gemcitabinecontaining magnetoliposome and oxaliplatincontaining magnetoliposome in breast cancer treatment: A possible mechanism with potential for clinical application |
|
https://doi.org/10.18632/oncotarget.9671
|
| 43762-43778 |
|
| AKR1B10 promotes breast cancer metastasis through integrin α5/δcatenin mediated FAK/Src/Rac1 signaling pathway |
|
https://doi.org/10.18632/oncotarget.9672
|
| 43779-43791 |
|
| IRE1α inhibition by natural compound genipin on tumour associated macrophages reduces growth of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.9696
|
| 43792-43804 |
|
| Aberrant methylationmediated silencing of microRNAs contributes to HPVinduced anchorage independence |
|
https://doi.org/10.18632/oncotarget.9698
|
| 43805-43819 |
|
| ER stress in temozolomidetreated glioblastomas interferes with DNA repair and induces apoptosis |
|
https://doi.org/10.18632/oncotarget.9907
|
| 43820-43834 |
|
| Long noncoding RNA RP11838N24 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR10a in glioblastoma cell lines |
|
https://doi.org/10.18632/oncotarget.9699
|
| 43835-43851 |
|
| Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells |
|
https://doi.org/10.18632/oncotarget.9700
|
| 43852-43867 |
|
| Quantitative proteomics reveals that distant recurrenceassociated protein RRas and Transgelin predict postsurgical survival in patients with Stage III colorectal cancer |
|
https://doi.org/10.18632/oncotarget.9701
|
| 43868-43893 |
|
| Wholeexome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study |
|
https://doi.org/10.18632/oncotarget.9707
|
| 43894-43906 |
|
| Ellagitanninrich cloudberry inhibits hepatocyte growth factor induced cell migration and phosphatidylinositol 3kinase/AKT activation in colon carcinoma cells and tumors in Min mice |
|
https://doi.org/10.18632/oncotarget.9724
|
| 43907-43923 |
|
| KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer |
|
https://doi.org/10.18632/oncotarget.9721
|
| 43924-43938 |
|
| Quantitative in vivo optical tomography of cancer progression & vasculature development in adult zebrafish |
|
https://doi.org/10.18632/oncotarget.9756
|
| 43939-43948 |
|
| Human pluripotent stem cell PSCderived mesenchymal stem cells MSCs show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement |
|
https://doi.org/10.18632/oncotarget.9947
|
| 43949-43959 |
|
| MLLT11/AF1q boosts oncogenic STAT3 activity through SrcPDGFR tyrosine kinase signaling |
|
https://doi.org/10.18632/oncotarget.9759
|
| 43960-43973 |
|
| Crucial factors of the inflammatory microenvironment IL1β/ TNFα/TIMP1 promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study |
|
https://doi.org/10.18632/oncotarget.9949
|
| 43974-43988 |
|
| Demonstration of potential link between Helicobacter pylori related promoter CpG island methylation and telomere shortening in human gastric mucosa |
|
https://doi.org/10.18632/oncotarget.9764
|
| 43989-43996 |
|
| BET inhibition as a new strategy for the treatment of gastric cancer |
|
https://doi.org/10.18632/oncotarget.9766
|
| 43997-44012 |
|
| MDM2 knockdown mediated by a triazinemodified dendrimer in the treatment of nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.9768
|
| 44013-44022 |
|
| MiR422a promotes locoregional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.9829
|
| 44023-44038 |
|
| Metaanalysis of the efficacy of the pretreatment neutrophiltolymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors |
|
https://doi.org/10.18632/oncotarget.9836
|
| 44039-44046 |
|
| Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNAdamage response after irradiation |
|
https://doi.org/10.18632/oncotarget.10057
|
| 44047-44061 |
|
| Cyr61 and YB1 are novel interacting partners of uPAR and elevate the malignancy of triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.9853
|
| 44062-44075 |
|
| Hepatitis B virus genotypes expression quantitative trait loci for ZNRD1AS1 and their interactions in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.9854
|
| 44076-44083 |
|
| Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.9857
|
| 44084-44095 |
|
| Breast cancer subtype dictates DNA methylation and ALDH1A3mediated expression of tumor suppressor RARRES1 |
|
https://doi.org/10.18632/oncotarget.9858
|
| 44096-44112 |
|
| UCN01 enhances cytotoxicity of irinotecan in colorectal cancer stemlike cells by impairing DNA damage response |
|
https://doi.org/10.18632/oncotarget.9859
|
| 44113-44128 |
|
| Silencing DNA methyltransferase 1 DNMT1 inhibits proliferation metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK |
|
https://doi.org/10.18632/oncotarget.9866
|
| 44129-44141 |
|
| Mitochondrial clearance by the STK38 kinase supports oncogenic Rasinduced cell transformation |
|
https://doi.org/10.18632/oncotarget.9875
|
| 44142-44160 |
|
| Aquaporin 9 inhibits hepatocellular carcinoma through upregulating FOXO1 expression |
|
https://doi.org/10.18632/oncotarget.10143
|
| 44161-44170 |
|
| Inhibition of histone deacetylases induces formation of multipolar spindles and subsequent p53dependent apoptosis in nasopharyngeal carcinoma cells |
|
https://doi.org/10.18632/oncotarget.9922
|
| 44171-44184 |
|
| Systemic immuneinflammation index thymidine phosphorylase and survival of localized gastric cancer patients after curative resection |
|
https://doi.org/10.18632/oncotarget.9923
|
| 44185-44193 |
|
| Missense mutations in the TP53 DNAbinding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.9925
|
| 44194-44210 |
|
| Multiplelevel validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease |
|
https://doi.org/10.18632/oncotarget.9954
|
| 44211-44223 |
|
| Dualtiming PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy |
|
https://doi.org/10.18632/oncotarget.10000
|
| 44224-44235 |
|
| Telomeric repeatbinding factor 2: a marker for survival and antiEGFR efficacy in oral carcinoma |
|
https://doi.org/10.18632/oncotarget.10005
|
| 44236-44251 |
|
| miR22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma prostate cancer cervical cancer and lung cancer |
|
https://doi.org/10.18632/oncotarget.10020
|
| 44252-44265 |
|
| MicroRNA187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.10023
|
| 44266-44276 |
|
| p63α modulates cMyc activity via direct interaction and regulation of MM1 protein stability |
|
https://doi.org/10.18632/oncotarget.10187
|
| 44277-44287 |
|
| Tumorinfiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A metaanalysis |
|
https://doi.org/10.18632/oncotarget.9988
|
| 44288-44298 |
|
| A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth |
|
https://doi.org/10.18632/oncotarget.9996
|
| 44299-44309 |
|
| iHydPseCp: Identify hydroxyproline and hydroxylysine in proteins by incorporating sequencecoupled effects into general PseAAC |
|
https://doi.org/10.18632/oncotarget.10027
|
| 44310-44321 |
|
| Molecular driver alterations and their clinical relevance in cancer of unknown primary site |
|
https://doi.org/10.18632/oncotarget.10035
|
| 44322-44329 |
|
| Study of single nucleotide polymorphisms of FBW7 and its substrate genes revealed a predictive factor for paclitaxel plus cisplatin chemotherapy in Chinese patients with advanced esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.9736
|
| 44330-44339 |
|
| Involvement of IL10 and TGFβ in HLAEmediated neuroblastoma migration and invasion |
|
https://doi.org/10.18632/oncotarget.10041
|
| 44340-44349 |
|
| Linking microsomal prostaglandin E synthase1/PGE2 pathway with miR15a and 186 expression: Novel mechanism of VEGF modulation in prostate cancer |
|
https://doi.org/10.18632/oncotarget.10051
|
| 44350-44364 |
|
| HMGA2 sustains selfrenewal and invasiveness of gliomainitiating cells |
|
https://doi.org/10.18632/oncotarget.9744
|
| 44365-44380 |
|
| Novel histopathologic feature identified through image analysis augments stage II colorectal cancer clinical reporting |
|
https://doi.org/10.18632/oncotarget.10053
|
| 44381-44394 |
|
| Evaluation of the prognostic value of tumorinfiltrating lymphocytes in triplenegative breast cancers |
|
https://doi.org/10.18632/oncotarget.10054
|
| 44395-44405 |
|
| Identification of Glypican3 as a potential metastasis suppressor gene in gastric cancer |
|
https://doi.org/10.18632/oncotarget.9763
|
| 44406-44416 |
|
| SPANXA suppresses EMT by inhibiting cJUN/SNAI2 signaling in lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.10088
|
| 44417-44429 |
|
| Prevention of pancreatic cancer in a hamster model by cAMP decrease |
|
https://doi.org/10.18632/oncotarget.9790
|
| 44430-44441 |
|
| Long noncoding RNA UCA1 is a predictive biomarker of cancer |
|
https://doi.org/10.18632/oncotarget.10142
|
| 44442-44447 |
|
| Down regulation of Chk1 by p53 plays a role in synergistic induction of apoptosis by chemotherapeutics and inhibitors for Jak2 or BCR/ABL in hematopoietic cells |
|
https://doi.org/10.18632/oncotarget.9844
|
| 44448-44461 |
|
| Prostate tumorinduced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species |
|
https://doi.org/10.18632/oncotarget.9852
|
| 44462-44477 |
|
| Infiltrating macrophages increase RCC epithelial mesenchymal transition EMT and stem celllike populations via AKT and mTOR signaling |
|
https://doi.org/10.18632/oncotarget.9873
|
| 44478-44491 |
|
| High expression of TROP2 characterizes different cell subpopulations in androgensensitive and androgenindependent prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.9876
|
| 44492-44504 |
|
| Synergy between histone deacetylase inhibitors and DNAdamaging agents is mediated by histone deacetylase 2 in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.9887
|
| 44505-44521 |
|
| OncomiR130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer |
|
https://doi.org/10.18632/oncotarget.9936
|
| 44522-44533 |
|
| TGFβ1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment |
|
https://doi.org/10.18632/oncotarget.10003
|
| 44534-44544 |
|
| Safety and efficacy profile of lenvatinib in cancer therapy: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.10019
|
| 44545-44557 |
|
| The long noncoding RNA HOTAIR increases tumour growth and invasion in cervical cancer by targeting the Notch pathway |
|
https://doi.org/10.18632/oncotarget.10065
|
| 44558-44571 |
|
| Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4dependent MAPK pathway |
|
https://doi.org/10.18632/oncotarget.10067
|
| 44572-44582 |
|
| Circulating cellfree DNA as a prognostic and predictive biomarker in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.10069
|
| 44583-44595 |
|
| Olinked Nacetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes |
|
https://doi.org/10.18632/oncotarget.10112
|
| 44596-44607 |
|
| Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy |
|
https://doi.org/10.18632/oncotarget.10115
|
| 44608-44620 |
|
| Convergent evidence from systematic analysis of GWAS revealed genetic basis of esophageal cancer |
|
https://doi.org/10.18632/oncotarget.10133
|
| 44621-44629 |
|
| Piezo2 protein: A novel regulator of tumor angiogenesis and hyperpermeability |
|
https://doi.org/10.18632/oncotarget.10134
|
| 44630-44643 |
|
| Maturation of dendritic cells by pullulan promotes anticancer effect |
|
https://doi.org/10.18632/oncotarget.10183
|
| 44644-44659 |
Clinical Research Papers
|
| Strategies to improve treatment outcome in gastric cancer: A retrospective analysis of patients from two highvolume hospitals in Korea and China |
|
https://doi.org/10.18632/oncotarget.9378
|
| 44660-44675 |
|
| Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer |
|
https://doi.org/10.18632/oncotarget.9225
|
| 44676-44685 |
|
| Concurrent cisplatin and 5fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity scorematched analysis |
|
https://doi.org/10.18632/oncotarget.9301
|
| 44686-44694 |
|
| Survival of patients with symptom and screeningdetected colorectal cancer |
|
https://doi.org/10.18632/oncotarget.9412
|
| 44695-44704 |
|
| Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multicenter comparative study |
|
https://doi.org/10.18632/oncotarget.9604
|
| 44705-44718 |
Reviews
|
| An overview of long noncoding RNAs in ovarian cancers |
|
https://doi.org/10.18632/oncotarget.8089
|
| 44719-44734 |
|
| Molecular and clinical significance of fibroblast growth factor 2 FGF2 /bFGF in malignancies of solid and hematological cancers for personalized therapies |
|
https://doi.org/10.18632/oncotarget.8203
|
| 44735-44762 |
|
| Cell apoptosis autophagy and necroptosis in osteosarcoma treatment |
|
https://doi.org/10.18632/oncotarget.8206
|
| 44763-44778 |
|
| From kinetics and cellular cooperations to cancer immunotherapies |
|
https://doi.org/10.18632/oncotarget.8242
|
| 44779-44789 |
|
| Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development |
|
https://doi.org/10.18632/oncotarget.8316
|
| 44790-44802 |
|
| A systematic review on in vitro 3D bone metastases models: A new horizon to recapitulate the native clinical scenario |
|
https://doi.org/10.18632/oncotarget.8394
|
| 44803-44820 |
|
| Molecules that target nucleophosmin for cancer treatment: an update |
|
https://doi.org/10.18632/oncotarget.8599
|
| 44821-44840 |
|
| How do the results of the RADIANT trials impact on the management of NET patients A systematic review of published studies |
|
https://doi.org/10.18632/oncotarget.8601
|
| 44841-44847 |
|
| Ubiquitinspecific peptidase 22 functions and its involvement in disease |
|
https://doi.org/10.18632/oncotarget.8602
|
| 44848-44856 |
|
| Waitandsee treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.8622
|
| 44857-44870 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
